oligonucleotide (Hoffmann-La Roche)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameoligonucleotide (Hoffmann-La Roche)
Drug Alias Nameoligonucleotide (Hoffmann-La Roche)oligonucleotide (Hoffmann-La Roche)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoffmann-La Roche Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoffmann-La Roche Inc
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A